Scienture Holdings (SCNX) Cash & Equivalents (2013 - 2026)

Scienture Holdings has reported Cash & Equivalents for 14 years, with the latest figure at $3.5 million in Q1 2026.

• Quarterly Cash & Equivalents rose 72.85% year-over-year to $3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 million (up 72.85% YoY) and the FY2025 annual result came in at $6.7 million, up 2062.32% from the prior year.
• Cash & Equivalents fell to $3.5 million in Q1 2026 per SCNX's latest filing, from $6.7 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $7.7 million in Q2 2024 and troughed at $15391.0 in Q2 2025.
• A 5-year average of $2.1 million and a median of $1.0 million in 2022 frame the typical range for Cash & Equivalents.
• The widest YoY moves for Cash & Equivalents: up 2062.32% in 2025, down 99.8% in 2025.
• Over 5 years, Cash & Equivalents stood at $1.1 million in 2022, then plunged by 86.13% to $151907.0 in 2023, then soared by 102.82% to $308096.0 in 2024, then jumped by 2062.32% to $6.7 million in 2025, then sank by 46.82% to $3.5 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $3.5 million, $6.7 million, and $15391.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.